1Baran R, Feuilhade M, Combernale P,et al. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J De
2Sigurgeirsson B, Olafsson JH, Steinsson JB, et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5 - year blinded prospective follow-up study. Arch Dermatol,2002, 138:353-357.
3Evans EG. Drug synergies and the potential for combination therapy in onychomycosis. Br J Dermatol, 2003, 149: 1 1 - 13.
4Roberts DT, Taylor WD, Boyle J, et al. Guidelines for treatment of onychomycosis. Br J Dermatol, 2003, 148:402 -410.
5Arenas R, Fernandez G, Dominguez L. Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. Int J Dermatol, 1991, 30:586 -589.
6Hay RJ, Clayton YM, Moore MK. A comparison of tioconazole 28%nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol, 1987, 12 (3): 175 - 177.
7Baran R. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. Br J Dermatol, 2001,145:15 - 19.
8Lecha M. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain. Br J Dermatol, 2001, 145:21 -26.
9Lambert J. Pharmacoeconomic issues in onychomycosis. Br J Dermatol, 2003, 149:19-22.
10Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. BMJ, 1999, 318:1031 - 1035.
